LithuaniaBIO and Life Sciences Companies Participated in the Advanced Therapies Congress 2025 on March 18–19

No category

On March 18–19, LithuaniaBIO, together with Lithuanian life sciences companies – Caszyme, Nando, Biomapas, VUGENE, LAIMA and Vital 3D Technologies – participated in Advanced Therapies Congress, the largest commercial cell and gene therapy conference and exhibition in Europe, held in London. The event brought together executives and top-level leaders from ATMP (Advanced Therapy Medicinal Products)…

New opportunities open for Lithuanian biotechnology, health technology and medical device companies in Boston Biotechnology and Life science cluster

No category

Boston and the state of Massachusetts in the United States are among the world’s centers for biotechnology and life sciences. Not only do companies such as Thermo Fisher Scientific, AmGen, BioGen, Pfizer, Moderna, Merck, Charles River Laboratories have their headquarters here, but the strongest research institutions like the Massachusetts Institute of Technology (MIT) and Harvard…

The founders of Biomatter Designs are included in the list of Forbes 30 under 30 – Europe 2022

No category

The founders of the biotechnology company Biomatter Designs Laurynas Karpus, Irmantas Rokaitis and Vykintas Jauniškis were included in the list of Forbes 30 under 30 Europe – 2022! Their biotech company, Biomatter Designs, has developed an AI platform to construct new protein products for therapeutic and manufacturing purposes. They say the patented process is more…

EuropaBio published policy recommendations for the healthcare and industrial biotechnology sectors

No category

PRESS RELEASE Brussels, 25 April 2022 EuropaBio today published the National Associations Council Summit 2022 Event Report ”Biotechnology: Delivering Europe’s industrial strategy across the sectors”. The report includes key policy recommendations for healthcare and industrial biotechnology sectors at national and the EU level which could serve the policymakers to get a better understanding of the sector’s…

Registration now open for #EFIB2022: benefit from the early bird fee!

No category

NEWS RELEASE    Brussels, Belgium – EFIB 2022 registration open as of 11 April 2022.   26-27 October 2022, more than 500 industry leaders, SMEs representatives, policy makers and academia are expected in Vilnius, Lithuania to join Europe’s leading event on industrial biotechnology and the bioeconomy under the title ‘“Next generation economies: Industrial biotechnology for…